SCHEMBL13799259

SCHEMBL13799259

CC(C)c1cc(-c2ccccc2)cc(F)c1C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 2/20 0.39
AKR1C1 Q04828 2/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
FFAR1 O14842 1/20 0.35
PTGS1 P23219 3/20 0.35
MEN1 O00255 2/20 0.35
PTGS2 P35354 2/20 0.35
KMT2A Q03164 2/20 0.35
FABP2 P12104 1/20 0.35
TSHR P16473 1/20 0.35
AKR1C4 P17516 1/20 0.35
ADRA2B P18089 1/20 0.35
CHRM3 P20309 1/20 0.35
HTR2C P28335 1/20 0.35
DRD3 P35462 1/20 0.35
AKR1C3 P42330 1/20 0.35
SLC22A6 Q4U2R8 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17878525 0.88 AKR1C2 (0.43) AKR1C2AKR1C1FFAR1PTGS1MEN1
SCHEMBL8674451 0.86 CA1 (0.44) CA1CA2PTGS2KDM4EHTT
SCHEMBL13799255 0.84 CA1 (0.36) CA1CA2PTGS1PTGS2LMNA
SCHEMBL21872207 0.81 ESR2 (0.40) AKR1C2AKR1C1PTGS1MEN1PTGS2
SCHEMBL13799256 0.80 NPC1 (0.43) CYP2C19RPS6KA3KDM4EHTTSMN1; SMN2
SCHEMBL13799268 0.79 CA1 (0.39) CA1CA2PTGS2LMNARPS6KA3
SCHEMBL18881092 0.77 FFAR1 (0.40) FFAR1MEN1PTGS2KMT2ALMNA
SCHEMBL20232996 0.77 FFAR1 (0.40) FFAR1MEN1PTGS2KMT2ALMNA
SCHEMBL25841973 0.77 FFAR1 (0.50) AKR1C2AKR1C1FFAR1ALOX5APFEN1
SCHEMBL10884746 0.75 CDC25A (0.39) CA1CA2FFAR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090145483-A1 Novel electroluminescent compounds and organic electroluminescent device suing the same GRACEL DISPLAY INC. (KR) 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090145483-A1 Novel electroluminescent compounds and organic electroluminescent device suing the same LEF1, ODC1, AOC2 AKR1C2 1878/4885AKR1C1 1460/4885CA1 2319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.